Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 2
1990 2
1991 1
1992 2
1995 2
1998 1
2000 1
2002 1
2004 2
2005 1
2007 2
2008 3
2009 2
2011 2
2012 2
2014 2
2015 1
2016 1
2018 2
2019 2
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Pinpointing the tumor-specific T cells via TCR clusters.
Goncharov MM, Bryushkova EA, Sharaev NI, Skatova VD, Baryshnikova AM, Sharonov GV, Karnaukhov V, Vakhitova MT, Samoylenko IV, Demidov LV, Lukyanov S, Chudakov DM, Serebrovskaya EO. Goncharov MM, et al. Among authors: demidov lv. Elife. 2022 Apr 4;11:e77274. doi: 10.7554/eLife.77274. Elife. 2022. PMID: 35377314 Free PMC article.
Improved survival with MEK inhibition in BRAF-mutated melanoma.
Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group. Flaherty KT, et al. Among authors: demidov lv. N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4. N Engl J Med. 2012. PMID: 22663011 Free article. Clinical Trial.
Somatostatin receptor type 2 expression in Merkel cell carcinoma as a prognostic factor.
Orlova KV, Delektorskaya VV, Vishnevskaya YV, Kondratieva TT, Orel NF, Markovich AA, Demidov LV, Subramanian S. Orlova KV, et al. Among authors: demidov lv. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e236-e237. doi: 10.1111/jdv.14769. Epub 2018 Jan 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29265481 No abstract available.
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy.
Mikhaylova IN, Shubina IZ, Chkadua GZ, Petenko NN, Morozova LF, Burova OS, Beabelashvili RS, Parsunkova KA, Balatskaya NV, Chebanov DK, Pospelov VI, Nazarova VV, Vihrova AS, Cheremushkin EA, Molodyk AA, Kiselevsky MV, Demidov LV. Mikhaylova IN, et al. Among authors: demidov lv. Oncotarget. 2018 May 11;9(36):24381-24390. doi: 10.18632/oncotarget.25274. eCollection 2018 May 11. Oncotarget. 2018. PMID: 29849947 Free PMC article.
Cancer/testis genes expression in human melanoma cell lines.
Mikhaylova IN, Kovalevsky DA, Morozova LF, Golubeva VA, Cheremushkin EA, Lukashina MI, Voronina ES, Burova OS, Utyashev IA, Kiselev SL, Demidov LV, Beabealashvilli RSh, Baryshnikov AY. Mikhaylova IN, et al. Among authors: demidov lv. Melanoma Res. 2008 Oct;18(5):303-13. doi: 10.1097/CMR.0b013e32830e391d. Melanoma Res. 2008. PMID: 18781128
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.
Hauschild A, Ascierto PA, Schadendorf D, Grob JJ, Ribas A, Kiecker F, Dutriaux C, Demidov LV, Lebbé C, Rutkowski P, Blank CU, Gutzmer R, Millward M, Kefford R, Haas T, D'Amelio A Jr, Gasal E, Mookerjee B, Chapman PB. Hauschild A, et al. Among authors: demidov lv. Eur J Cancer. 2020 Jan;125:114-120. doi: 10.1016/j.ejca.2019.10.033. Eur J Cancer. 2020. PMID: 31864178 Free PMC article. Clinical Trial.
Melanoma arising in a Giant congenital melanocytic nevus: two case reports.
Belysheva TS, Vishnevskaya YV, Nasedkina TV, Emelyanova MA, Abramov IS, Orlova KV, Lubchenko LN, Utyashev IA, Doroshenko MB, Demidov LV, Aliev MD. Belysheva TS, et al. Among authors: demidov lv. Diagn Pathol. 2019 Feb 19;14(1):21. doi: 10.1186/s13000-019-0797-1. Diagn Pathol. 2019. PMID: 30782194 Free PMC article.
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Orlova KV, Ledin EV, Zhukova NV, Orlova RV, Karabina EV, Volkonskiy MV, Stroyakovskiy DL, Yurchenkov AN, Protsenko SA, Novik AV, Vorotilina LV, Moiseenko FV, Chang VL, Kazmin AI, Tkachenko SA, Gamaunov SV, Naskhletashvili DR, Samoylenko IV, Vikhrova AS, Utyashev IA, Kharkevich GY, Petenko NN, Shubina IZ, Demidov LV. Orlova KV, et al. Among authors: demidov lv. Cancers (Basel). 2021 May 21;13(11):2529. doi: 10.3390/cancers13112529. Cancers (Basel). 2021. PMID: 34064013 Free PMC article.
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, Rutkowski P, Blank CU, Miller WH Jr, Kaempgen E, Martín-Algarra S, Karaszewska B, Mauch C, Chiarion-Sileni V, Martin AM, Swann S, Haney P, Mirakhur B, Guckert ME, Goodman V, Chapman PB. Hauschild A, et al. Among authors: demidov lv. Lancet. 2012 Jul 28;380(9839):358-65. doi: 10.1016/S0140-6736(12)60868-X. Epub 2012 Jun 25. Lancet. 2012. PMID: 22735384 Clinical Trial.
[ Spectrum of oncogene mutations is different in melanoma subtypes].
Mazurenko NN, Tsyganova IV, Lushnikova AA, Ponkratova DA, Anurova OA, Cheremushkin EA, Mikhailova IN, Demidov LV. Mazurenko NN, et al. Among authors: demidov lv. Mol Biol (Mosk). 2015 Nov-Dec;49(6):1022-9. doi: 10.7868/S0026898415060166. Mol Biol (Mosk). 2015. PMID: 26710785 Free article. Russian.
39 results